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The dual burden of human immunodeficiency virus (HIV) and 
tuberculosis (TB) dominates the health landscape of South Africa 
(SA), with approximately 5.5 million HIV-infected people and a 
TB incidence of about 1 000/100 000 population.1 Up to 85% of 
new TB patients are co-infected with HIV, and together HIV and 
TB constitute the largest burden of premature mortality in SA, 
accounting for 22% of years of life lost.2 This overwhelming burden 
diverts attention from other infections that contribute significantly 
to mortality; lower respiratory tract infections, intestinal infectious 
diseases and septicaemia together accounted for 7.4% of years of life 
lost in 2009.2 Furthermore, poor infection control, a lack of proper 
antibiotic stewardship and irresponsible antibiotic prescribing in the 
public and private sectors has led to an increase in hospital-acquired 
infections (HAIs) and multidrug-resistant bacteria.3 HAIs increase 
morbidity, lengthen hospital stay (and costs), and impact negatively 
on in-hospital mortality.4 Imported infections also pose a significant 
threat to public health; the influenza pandemic of 2009 was a stark 
reminder of this potential threat, amid public panic and inability of 
an already overstretched health infrastructure to easily cope with the 
additional burden of infection.
Against this backdrop, infectious diseases (ID) became a recognised 
medical sub-specialty in SA in 2005. The challenge was to develop 
services at tertiary level hospitals that could support the primary 
and secondary level hospitals to cope with HIV-TB epidemics and 
all other infections. ID units became responsible for training sub-
specialists, general physicians and paediatricians, allied healthcare 
workers, and medical students in ID. The challenges of providing 
specialist ID care and training are formidable, given the shortage of 
trained ID specialists and the lack of resources.
In April 2007, the Division of Infectious Diseases and HIV 
Medicine was established as a division of the Department of Medicine 
at Groote Schuur Hospital (GSH). In this article we describe the work 
of the ID unit and discuss the need to refocus SA’s priorities towards 
training of physicians and allocation of resources to ID, in line with 
the burden of disease.
Methods
The GSH ID unit runs an inpatient consulting system, including 
out-of-hours emergency consultations, whereby referred patients are 
seen on a same-day basis by a junior member of the team and then 
by the consultant on call. Patients are co-managed with their primary 
medical team and are followed up daily until discharge or resolution 
of the infection episode. A prospective patient database was started 
in January 2008 to record the following clinical information: sex, 
referring team, HIV status (CD4 T-cell count, antiretroviral therapy 
(ART) on admission, ART during hospitalisation (including starts 
and changes), presenting clinical features, results of follow-up, final 
discharge diagnosis, presence of co-morbidity, death, and cause of 
death where known. The study was approved by the Human Research 
and Ethics Committee of the University of Cape Town.
A database was constructed to capture patient consultations. 
The database was checked weekly for inaccuracies by a consultant. 
Telephone consultations were not recorded. The discharge diagnosis 
and any co-morbidity data were captured. Statistical analysis was 
performed using STATA-10 software. 
Results
The ID service at GSH was consulted by 2 142 patients over the 4-year 
period of 2008 - 2011, averaging 535 patients per year. Almost two-
thirds of referrals were from the Department of Medicine, with 37 
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Background. The greatest burden of disease in South Africa (SA) 
comes from infectious diseases (ID), with human immunodeficiency 
virus (HIV) and tuberculosis (TB) dominating the health landscape. 
However, other infections including community-acquired and 
imported infections and the rise in hospital-acquired infections 
pose a considerable threat to public health.
Methods and objectives. We used a prospective cross-sectional 
study to examine the profile of patients referred to the Infectious 
Diseases Unit at Groote Schuur Hospital (GSH) between 2008 
and 2011.
Results. A total of 2 142 patient consultations were performed, the 
majority at the request of secondary hospital level medical teams; 
80% of patients were HIV-infected (with a median CD4 count of 
128/mm3). Approximately half of antiretroviral-naïve, HIV-infected 
patients started antiretroviral therapy in hospital. TB, predominantly 
extrapulmonary, was the most common diagnosis. Imported 
infections, notably severe falciparum malaria, accounted for a large 
number of the 81 different diagnoses in HIV-seronegative patients. 
Over half of all patients had co-morbidity complicating their clinical 
presentation. In-hospital mortality was 5.8%, with overwhelming 
sepsis the cause in 40% of deaths, largely due to hospital-acquired 
infection, particularly in the HIV-infected cohort.
Conclusion. The overwhelming burden of ID in SA is revealed 
in this experience at GSH, a tertiary level referral hospital serving 
the Cape metropolitan area. The needs of the population warrant 
a reappraisal of human resource capacity and training in ID in SA.
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- 42% of referrals from secondary level medical teams and 15 - 22% 
from tertiary level medical sub-specialties. Dermatology accounted 
for 56% of all referrals over the 4 years, more than twice those from 
neurology, the second highest referring sub-specialty. In contrast to 
the predominance of general medical referrals, two-thirds of referrals 
from the Department of Surgery came from surgical sub-specialties 
such as vascular surgery and ENT departments, and only one-third 
from secondary level General Surgery. Together, the Departments of 
Obstetrics, Psychiatry and the Emergency and Intensive Care Units 
contributed 20% of all referrals. 
HIV-infected patients
Approximately 80% of patients were HIV-infected and had markedly 
low CD4 counts (median 128/mm3). The percentage of HIV-
infected patients did not change significantly over time; however, the 
percentage of patients admitted to GSH on ART increased from 37.1% 
to 48.1% between 2008 and 2011. Notably, this was not associated 
with an increase in the median CD4 count on admission for those 
patients on ART. A total of 444 HIV-infected patients started ART 
while in hospital, typically as part of an accelerated programme for 
patients with very low CD4 counts (<100 /mm3), followed by those 
with HIV-associated illnesses, the pathogenesis of which was related 
to HIV replication, e.g. HIV-related idiopathic thrombocytopenic 
purpura. ART was also commenced for untreatable opportunistic 
infections such as cryptosporidiosis.
TB was the discharge diagnosis in the majority of HIV-infected 
patients referred to the ID unit. In total, 665 of 1 749 (38%) HIV-
infected patients had TB; this was the primary diagnosis in two-thirds 
of cases, and a co-morbid illness in the remaining third. Pulmonary 
TB was the commonest form of the disease, followed by disseminated, 
meningeal and abdominal TB. Multidrug-resistant TB was recorded in 
17 (4%) cases and a paradoxical immune reconstitution inflammatory 
syndrome (IRIS) in a further 4%. Second after TB as a reason for 
consultation, were drug hypersensitivity syndromes (Stevens-Johnson 
syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia 
and systemic symptoms) in 286 (16%) patients (Fig. 1). Anti-TB 
drugs were implicated in 61 out of 286 (21%) drug hypersensitivity 
syndrome cases, with non-nucleoside reverse transcriptase inhibitors 
and co-trimoxazole each implicated in a similar number. Cancer 
(lymphoma, Kaposi’s sarcoma and non-AIDS-defining cancers) as 
primary diagnosis accounted for 11% of all referrals. Overall, 54% of 
patients had a co-morbid condition that was either directly linked to 
HIV, such as opportunistic infection, or non-HIV-related illness such 
as acute renal failure, frequently the result of bacterial sepsis.
HIV-seronegative patients
The ID unit consulted on 385 HIV-seronegative patients, with 81 
different diagnoses. TB was again the dominant primary diagnosis 
in 70 (18%) patients, and was a co-morbid infection in a further 24 
(Fig. 2). A total of 58 patients were admitted with severe Plasmodium 
falciparum malaria; 56 were men and 38 (65%) were Somali 
immigrants. Half of all HIV-seronegative patients had a co-morbid 
condition such as diabetes, which compounded the seriousness of 
their primary illness. There were no significant differences between 
the referral sources of HIV-seronegative and HIV-infected patients, 
the majority of referrals originating from the Department of Medicine.
Mortality
Overall, there were 125/2 142 (5.8%) deaths, 95/1 654 in the HIV-
infected group and 30/281 in HIV-uninfected patients (with p=0.002 
for the difference between the two groups). Overwhelming sepsis 
was the cause of death in 50 (40%) patients; in 45 (36%) the cause of 
death was uncertain. The remaining deaths were from end-stage TB, 
cancer, respiratory failure and severe falciparum malaria (3 cases). 
Postmortem examination was rarely performed.
Hospital-acquired infection (HAI)
There were 52 cases of HAI among HIV-infected patients, of whom 
20 (38%) died. Three of 12 (25%) HIV-seronegative patients died 
as a result of HAI. The pathogen was not identified in 60% of cases 
of HAI resulting in death, typically due to omission of cultures 
prior to empirical prescribing of antibiotics. Pseudomonas aeruginosa, 
Acinetobacter baumannii and methicillin-resistant Staphylococcus 
aureus (MRSA) were isolated, with extended-spectrum β-lactamase-
producing Klebsiella pneumoniae the commonest bacterium isolated 
(in 5 cases).
Discussion
In the GSH ID unit 80% of the workload was HIV-related. The 
predominance of TB as the primary diagnosis in HIV-related 
Fig. 2. Top 10 primary diagnoses in HIV-seronegative patients, 2008 - 2011.
Fig. 1. Main primary diagnoses and co-morbid illnesses in HIV-infected patients, 
excluding tuberculosis. PML = progressive multifocal leuco-encephalopathy; 
ITP = idiopathic thrombocytopenic purpura; PCP = pneumocystis pneumonia; 
TTP = thrombotic thrombocytopenic purpura.
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consultations is in keeping with the massive burden of HIV-TB in 
the population. HIV-TB cases were predominantly extrapulmonary, 
affecting one or multiple (disseminated) sites. Nearly half of all HIV-
infected patients not on ART, were adjudged to need to start ART 
in hospital, such was the advanced nature of their disease or the 
inherent role of HIV in the pathogenesis of their presenting illness. 
While in HIV-seronegative patients TB was again predominant, the 
role of the ID unit in managing very sick patients with falciparum 
malaria in a non-endemic province, attests to the importance of such 
units in guiding management of imported infections. HAIs were an 
important cause of in-hospital mortality, particularly in the HIV-
infected cohort.
HIV-infected patients continue to be admitted to hospital with 
complications of advanced HIV infection in spite of significant 
advances in the number of patients starting ART at primary 
clinics since 2004. In Khayelitsha, Médecins sans Frontières (MSF) 
documented an increase in annual enrolment of patients to ART 
from 80 in 2001 to 2 087 in 2007,5 with the median CD4 count 
of patients starting ART increasing from 43 to 162/mm3 between 
2001 and 2010.6 Our hospitalised HIV patient cohort also showed 
an increase in the number admitted on ART from 37.1% to 48.1% 
over the 4-year period, although the median CD4 count remained 
static, reflecting perhaps the reduction in CD4 count that occurs in 
the setting of acute illness, or poor adherence with failure of ART. 
Forty-two per cent of hospitalised ART-naïve HIV-infected patients 
were started on ART in hospital, the commonest reason being a low 
CD4 count, which qualifies the patient for accelerated start under 
national guidelines. A significant proportion of patients starting ART 
in hospital were diagnosed with either AIDS-related or unrelated 
cancers, the rationale being to reduce the driving force of HIV in 
pathogenesis of AIDS-related cancers and/or to boost immunity, 
which might reduce recurrence or progression.
The dominance of TB as the primary diagnosis in HIV-positive 
and HIV-seronegative patients is not surprising, considering the 
massive burden of TB in the local population. The fact that over 
60% of patients had extrapulmonary TB (EPTB) or disseminated TB 
reflects not only the increase in EPTB in HIV-infected patients in 
general, but the fact that EPTB more commonly presents a greater 
diagnostic challenge, requiring either a more experienced specialist 
opinion or diagnostic tests that are only available at a tertiary centre. 
Many of the HIV-TB cases presented as pyrexias of unknown origin, 
where baseline work-up had not revealed the diagnosis, or with 
drug resistance, TB-IRIS, or multiple opportunistic infections. The 
influence and burden of TB was also evident in patients presenting 
with drug hypersensitivity syndromes, one-fifth of which were related 
to anti-TB drugs.
The fact that over half of all patients had multiple co-morbidities, 
chief of which was bacterial sepsis, is a further indicator of the 
complexity of these cases. The most extreme example was an HIV-
infected patient diagnosed with concurrent cryptococcal meningitis, 
pulmonary TB, Pneumocystis jirovecii pneumonia, chronic hepatitis B, 
oesophageal candidiasis and herpes genitalis.
The skewed distribution of HIV-infected patients may reflect a 
bias in referring practice. HIV is a relatively new infection in the 
daily practice of many physicians, who might not have been trained 
in management of HIV disease as medical students and junior 
doctors; their lack of confidence in treating HIV patients may lead 
to over-referral. In addition, the fact that GSH policy permitted only 
the ID team to initiate ART increased the referral of HIV-infected 
patients. Conversely, until recently, non-HIV-related ID was the sole 
realm of the general specialist, and hence an ID referral might not 
be considered necessary for many complex cases. However, because 
the majority of deaths from falciparum malaria in South Africa 
result from poor recognition and poor inpatient management,7 the 
3 deaths that occurred in this cohort being no exception, such ID 
medical emergencies should preferably be co-managed by a trained 
ID sub-specialist. Our cohort of HIV-seronegative patients included 
81 different diagnoses, many of which a general specialist would have 
little or no experience in managing, e.g. African trypanosomiasis, 
human fascioliasis, and botryomycosis.
While the burden of disease from HIV in SA is well documented,8 
there have been no prospective studies detailing the contribution of 
ID units at tertiary institutions. Our study is the first in the country 
to document the range of patients seen by ID sub-specialists in a 
hospitalised cohort.
The limitations of this study include those inherent in all analyses 
of clinical databases over time, namely completeness and accuracy of 
data capture. Data were entered and checked by the same physicians 
and the discharge diagnoses entered by an experienced ID sub-
specialist. Our observations are limited to the inpatient clinical 
course and no comment on outcome after discharge is possible, as 
patients were not followed up after discharge. 
The major limitation of this study is its inability to convey the 
work of our unit, other than formal inpatient consultations. We 
support other hospitals and physicians outside of GSH, via telephonic 
consultations, and advise on patients who do not require admission. 
We provide outreach and support to secondary level hospitals and to 
district level hospitals providing dedicated specialist TB services (in 
the form of ward rounds, outpatient clinics and teaching). As 1 of 
only 5 HPCSA-accredited ID training units in the country, we train 
ID sub-specialists, medical and family practitioner registrars, medical 
officers, students and allied healthcare practitioners in ID and HIV 
medicine. Positioned within our unit is the Cape Town GeoSentinel 
Travel Surveillance Site, which studies illness in travellers, who act 
as sentinels for new outbreaks and new infections, e.g. severe acute 
respiratory syndrome (SARS) in 2003.
The role that our unit plays in infection prevention and control 
(IPC) and antibiotic stewardship in the hospital is also not fully 
elucidated in this study. Like most institutions in the public sector, 
infection control is under-resourced and poorly practised. In general, 
prescribing habits of physicians are sub-standard and contribute 
to the rising incidence of multidrug-resistant bacterial infections. 
A recent pilot survey of antibiotic prescribing practice on medical 
wards at GSH revealed that an average of 62% of patients are 
prescribed one or more antibiotics, with 48% of prescriptions 
containing errors (M Mendelson – unpublished observations). These 
include a lack of indication for antibiotics, inappropriate duration 
of therapy, the use of multiple antibiotics with overlapping spectra, 
and incorrect dosing. ID trainees spend 6 months in the laboratory 
and 18 months on clinical service, during which they learn rational 
antibiotic prescribing and to lead antibiotic stewardship teams in 
tertiary and secondary level hospitals. Our team augments the work 
of the hospital’s IPC sisters by training, advising wards on appropriate 
IPC, and participating in policy development.
Our findings generate a number of research questions that need 
to be addressed: among patients commencing ART as inpatients, 
what is their long-term outcome and does it differ from patients who 
are started on ART in outpatient clinics? (A recent study from the 
Eastern Cape showed that retention in care was reduced if pregnant 
women were started on ART as inpatients,9 perhaps because 
pregnant women view ART as primarily to protect their babies). Is 
HAI, as a cause of death in HIV-infected patients, peculiar to tertiary 
hospital inpatients or does it apply to all HIV-infected hospitalised 
patients?
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Human resource capacity building lags behind the national burden 
of ID. The complexity of patients described in this study, which is 
mirrored at secondary and district level hospitals, demands either 
an increase in the number of sub-specialists at tertiary level who 
can support the secondary and primary levels through outreach and 
support, or a national policy to appoint ID-trained subspecialists at 
secondary level hospitals to provide support also at the primary level. 
As capacity building will be a long-term project, a policy decision 
that all medical and family practitioner registrars rotate through a 
recognised ID unit as part of their training should be put into effect 
without delay.
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